Related Experiment Videos
Update on the management of hyperuricemia and gout
Michael H Pillinger1, Robert T Keenan
1New York Universuty School of Medicine, New York, NY, USA. michael.pillinger@med.nyu.edu
Insights
Gout management is evolving. New dietary strategies and emerging FDA-approved medications offer improved control for hyperuricemia and better treatment options for gout patients.
Area of Science:
- Rheumatology
- Immunology
- Pharmacology
Background:
- Gout is the most prevalent inflammatory arthritis in the U.S., affecting over three million individuals.
- Current gout management strategies have seen minimal advancement in 50 years.
- Many patients face contraindications to existing gout therapies.
Purpose of the Study:
- To review recent advancements in gout management.
- To highlight new insights into dietary interventions for hyperuricemia control.
- To discuss emerging pharmacological treatments for gout.
Main Methods:
- Literature review of recent updates in gout management.
- Analysis of new data on dietary interventions for hyperuricemia.
- Evaluation of biological and clinical data for novel gout drugs.
Main Results:
- Recent insights into gout pathophysiology indicate a need for updated treatment approaches.
- Novel dietary management strategies show promise for better hyperuricemia control.
- Emerging drugs demonstrate potential for FDA approval and clinical use.
Conclusions:
- The field of gout management is poised for significant change.
- New dietary and pharmacological options are expected to improve patient outcomes.
- Advances in understanding gout pathophysiology are driving therapeutic innovation.
Abstract:
Gout is the most common inflammatory arthritis in the United States, with more than three million sufferers. Management of gout has changed relatively little in the past 50 years, despite the fact that many gout patients have contraindications to one or more currently available gout therapies. However, recent insights into gout pathophysiology suggest that time is ripe for a change. This article reviews recent updates in the management of gout, including new insights into dietary management that may permit better control of hyuperuricemia. Also reviewed are the biological and clinical data behind newly-developed drugs for gout that are likely to receive serious consideration for FDA approval, and clinical use, in the foreseeable future.
Related Concept Videos
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Urinary Tract Calculi V: Nursing Management
Nephrotic Syndrome II : Assessment and Medical Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Calculi VI: Surgical Management